PDCD1 and non-small cell lung carcinoma: An example highlighting the importance of coordination in generating evidence that addresses global questions comes from the 2021 WHO model list application for anti-PD1 (programmed cell death protein 1) inhibitors to treat non-small cell lung cancer.